Guardian Pharmacy Services, Inc.
GRDN
$20.65
-$0.27-1.29%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.89% | 110.60% | -- | -- | -40.96% |
| Total Depreciation and Amortization | 2.21% | 3.18% | -- | -- | 0.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -27.66% | -95.17% | -- | -- | 138.92% |
| Change in Net Operating Assets | -63.77% | 95.77% | -- | -- | -163.24% |
| Cash from Operations | -21.43% | 1,132.21% | -- | -- | -40.54% |
| Capital Expenditure | -28.97% | 12.21% | -- | -- | -33.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -1.49% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 104.72% | -51.71% | -- | -- | -94.18% |
| Cash from Investing | 16.29% | 6.45% | -- | -- | -213.69% |
| Total Debt Issued | -- | -100.00% | -- | -- | -19.16% |
| Total Debt Repaid | 97.51% | 43.22% | -- | -- | 24.75% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | 28.70% |
| Other Financing Activities | 51.33% | 94.84% | -- | -- | 23.98% |
| Cash from Financing | 94.48% | -207.45% | -- | -- | 57.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 128.68% | -191.25% | -- | -- | -541.22% |